Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


2 Aging (Albany NY)
1 Ann Med
1 Ann Transl Med
1 Asia Ocean J Nucl Med Biol
1 BMC Cancer
1 Cancer Cell
1 Curr Oncol Rep
1 Ecotoxicol Environ Saf
1 Exp Ther Med
1 Front Bioeng Biotechnol
2 Front Oncol
1 Future Sci OA
1 Hinyokika Kiyo
1 Int J Cancer
1 Int J Mol Sci
1 Int Urol Nephrol
1 J Cancer Res Ther
1 J Endourol
6 J Urol
2 Lancet Oncol
1 Medicine (Baltimore)
1 Oncologist
1 Open Med (Wars)
2 Pathol Oncol Res
1 Scand J Urol
1 Sci Transl Med
1 Tuberk Toraks
1 Urol J
2 Urol Oncol
2 Urologiia
1 World J Urol

    Aging (Albany NY)

  1. CHEN MK, Zhou JH, Wang P, Ye YL, et al
    BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
    Aging (Albany NY). 2021;13.
    >> Share

  2. XU X, Xie B, Li S, Wang S, et al
    Association of dietary tomato intake with bladder cancer risk in a prospective cohort of 101,683 individuals with 12.5 years of follow-up.
    Aging (Albany NY). 2021;13.
    >> Share

    Ann Med

  3. HAO H, Chen H, Xie L, Liu H, et al
    YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.
    Ann Med. 2021;53:1169-1177.
    >> Share

    Ann Transl Med

  4. CHEN H, Liu Y, Cao C, Xi H, et al
    CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.
    Ann Transl Med. 2021;9:761.
    >> Share

    Asia Ocean J Nucl Med Biol

  5. GHORBANI H, Zarifmahmoudi L, Sadeghi R, Soltani S, et al
    Bowel visualization on the lymphoscintigraphy images of a bladder cancer patient due to inadvertent injection of the tracer in the rectal wall.
    Asia Ocean J Nucl Med Biol. 2021;9:177-179.
    >> Share

    BMC Cancer

  6. FU Y, Sun S, Bi J, Kong C, et al
    A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
    BMC Cancer. 2021;21:810.
    >> Share

    Cancer Cell

  7. MEZA L, Salgia NJ, Patel KC, Pal SK, et al
    Learning from BISCAY: The future of biomarker-based trial design in bladder cancer.
    Cancer Cell. 2021;39:910-912.
    >> Share

    Curr Oncol Rep

  8. SLOVACEK H, Zhuo J, Taylor JM
    Approaches to Non-Muscle-Invasive Bladder Cancer.
    Curr Oncol Rep. 2021;23:105.
    >> Share

    Ecotoxicol Environ Saf

  9. LOU Y, Ma C, Liu Z, Shi J, et al
    Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy.
    Ecotoxicol Environ Saf. 2021;221:112420.
    >> Share

    Exp Ther Med

  10. SPASOVA V, Mladenov B, Rangelov S, Hammoudeh Z, et al
    Clinical impact of copy number variation changes in bladder cancer samples.
    Exp Ther Med. 2021;22:901.
    >> Share

    Front Bioeng Biotechnol

  11. JANEV A, Ramuta TZ, Tratnjek L, Sardoc Z, et al
    Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models.
    Front Bioeng Biotechnol. 2021;9:690358.
    >> Share

    Front Oncol

  12. WANG R, Zheng Z, Mao S, Zhang W, et al
    Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:632459.
    >> Share

  13. DONG Y, Ma WM, Shi ZD, Zhang ZG, et al
    Role of NRP1 in Bladder Cancer Pathogenesis and Progression.
    Front Oncol. 2021;11:685980.
    >> Share

    Future Sci OA

  14. FERRO M, Baba DF, de Cobelli O, Musi G, et al
    Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.
    Future Sci OA. 2021;7:FSO709.
    >> Share

    Hinyokika Kiyo

  15. HIRANO S, Matsumoto K, Shiono Y, Nakamura M, et al
    [Clinicopathological Characteristics of Adolescent and Young-Adult Patients with Bladder Cancer].
    Hinyokika Kiyo. 2021;67:221-224.
    >> Share

    Int J Cancer

  16. VAN DOEVEREN T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, et al
    The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    Int J Cancer. 2021;148:981-987.
    >> Share

    Int J Mol Sci

  17. ERMAN A, Kamensek U, Dragin Jerman U, Pavlin M, et al
    How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.
    Int J Mol Sci. 2021;22.
    >> Share

    Int Urol Nephrol

  18. KOIE T, Hashimoto Y, Imai A, Yoneyama T, et al
    Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
    Int Urol Nephrol. 2021;53:275-280.
    >> Share

    J BUON

  19. TZELVES L, Xenou D, Skolarikos A, Varkarakis I, et al
    Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies.
    J BUON. 2021;26:1040-1055.
    >> Share

  20. GOKYER A, Kucukarda A, Kostek O, Sayin S, et al
    The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment.
    J BUON. 2021;26:1034-1039.
    >> Share

    J Cancer Res Ther

  21. WANG Z, Han C, Xu Y, Yu X, et al
    The role of prostate-specific antigen and multiparametric magnetic resonance imaging in the diagnosis of granulomatous prostatitis induced by intravesical Bacillus Calmette-Guerin vaccine therapy in patients with nonmuscle invasive bladder cancer.
    J Cancer Res Ther. 2021;17:625-629.
    >> Share

    J Endourol

  22. BABOUDJIAN M, Tadrist A, Lechevallier E
    Response to Editorial Comment: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?" by Tadrist e
    J Endourol. 2021;35:1049-1050.
    >> Share

    J Urol

  23. WYMER KM, Sharma V, Saigal CS, Chamie K, et al
    Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guerin-Unresponsive Carcinoma In Situ of the Bladder.
    J Urol. 2021;205:1326-1335.
    >> Share

  24. MATULEWICZ RS, Basak R, Zambrano I, Dearing BA, et al
    Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis.
    J Urol. 2021;205:1444-1451.
    >> Share

  25. HASHEM A, Abol-Enein H, Laymon M, Abdellutif MM, et al
    A Randomized Trial to Examine the Utility of Mebeverine on the Early Return of Continence Following Orthotopic Bladder Substitution.
    J Urol. 2021;205:1400-1406.
    >> Share

  26. WOLDU SL, Ng CK, Loo RK, Slezak JM, et al
    Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.
    J Urol. 2021;205:1387-1393.
    >> Share

  27. SCHOENBERG M, Steinberg G
    Rethinking the Treatment of Recurrent Nonmuscle-Invasive Bladder Cancer.
    J Urol. 2021;206:7-9.
    >> Share

  28. PIERETTI A, Krasnow R, Drumm M, Gusev A, et al
    Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy.
    J Urol. 2021;206:29-36.
    >> Share

    Lancet Oncol

  29. POWLES T, Csoszi T, Ozguroglu M, Matsubara N, et al
    Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
    Lancet Oncol. 2021;22:931-945.
    >> Share

  30. ZENGIN ZB, Meza L, Pal SK, Grivas P, et al
    Chemoimmunotherapy in urothelial cancer: concurrent or sequential?
    Lancet Oncol. 2021;22:894-896.
    >> Share

    Medicine (Baltimore)

  31. SHEN C, Zhou K, Wang W, Zhang Y, et al
    The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor: A prospective cohort study.
    Medicine (Baltimore). 2021;100:e26548.
    >> Share


  32. GEORGE S, Bell EJ, Zheng Y, Kim R, et al
    The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist. 2021;26:e1205-e1215.
    >> Share

    Open Med (Wars)

  33. ZHU J, Zhang F
    Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells.
    Open Med (Wars). 2021;16:1010-1021.
    >> Share

    Pathol Oncol Res

  34. CHEN M, Nie Z, Cao H, Gao Y, et al
    Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Pathol Oncol Res. 2021;27:598460.
    >> Share

  35. JEONG H, Oh HE, Kim H, Lee JH, et al
    Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer.
    Pathol Oncol Res. 2021;27:594705.
    >> Share

    Scand J Urol

    The devil is in the selected details: second-look resection in T1 bladder cancer.
    Scand J Urol. 2021 Jul 13:1. doi: 10.1080/21681805.2021.1948099.
    >> Share

    Sci Transl Med

  37. CHRYSOSTOMOU S, Roy R, Prischi F, Thamlikitkul L, et al
    Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
    Sci Transl Med. 2021;13.
    >> Share

    Tuberk Toraks

  38. OZGUL HA, Altay C, Basara Akin I, Bozkurt O, et al
    [Evaluation of solid pulmonary nodules in patients with bladder cancer with computed tomography based texture analysis method: Is it possible to differentiate metastatic - non-metastatic nodules?]
    Tuberk Toraks. 2021;69:227-236.
    >> Share

    Urol J

  39. LUO C, Lei T, Zhao M, Meng Q, et al
    The Role of NPM1 in the Invasion and Migration of Drug Resistant Bladder Cancer.
    Urol J. 2021 Jul 6. pii: 6087. doi: 10.22037/uj.v18i.6087.
    >> Share

    Urol Oncol

  40. SCHULZ GB, Todorova R, Braunschweig T, Rodler S, et al
    PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
    Urol Oncol. 2021 Jul 11. pii: S1078-1439(21)00260.
    >> Share

  41. LAUKHTINA E, Mori K, D Andrea D, Moschini M, et al
    Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    Urol Oncol. 2021 Jul 12. pii: S1078-1439(21)00267.
    >> Share


  42. KOMYAKOV BK, Sergeev AV, Fadeev VA, Al-Attar TH, et al
    [Long-term results of radical surgery treatment of patients with bladder cancer].
    Urologiia. 2021;:104-109.
    >> Share

  43. ZUBKOV AY, Nuriev IR, Sitdykova ME
    [Improvement of oncologic results of transurethral resection in the treatment of non-muscle-invasive bladder cancer].
    Urologiia. 2021;:110-113.
    >> Share

    World J Urol

  44. WEYERER V, Stoehr R, Bertz S, Lange F, et al
    Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
    World J Urol. 2021 Jul 14. pii: 10.1007/s00345-021-03788.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016